Ivermectin for COVID-19
4th treatment shown to reduce risk in
August 2020, now with p < 0.0000000001 from 106 studies, recognized in 24 countries.
No treatment is 100% effective.
Protocols combine treatments.
Analysis of the effect of ivermectin on the gut microbiome, showing a significant increase in Bifidobacterium.
Bifidobacterium plays a key role in the immune system, for example enhancing antibody production, facilitating the induction of regulatory T cells, modulating the immune response of macrophages, dendritic cells, and T cells, maintaining gut barrier integrity, and inhibiting harmful microbes.
Increased Bifidobacterium is associated with lower COVID-19 severity1.
Study covers probiotics and ivermectin.
Hazan et al., 22 Oct 2023, preprint, 4 authors.